Claire Mazumdar, CEO: Bicara Therapeutics BCAX Sell · Filed 05/20

Trade details

Type: Insider sale
Amount: $239,959.12
Shares · price: 12,022 sh · $19.96 a share
Held after: 365,130 sh
Stock: Bicara Therapeutics BCAX
Person: Claire MazumdarCEO
Trade date: 26/05/18
Filed: 26/05/20
Days to filing: 2 days

Sold 3.2% of holdings

Share of holding sold: 3.2%

Bicara Therapeutics trades, last 26 weeks

What else happened in Bicara Therapeutics around then

Filed or reported within 30 days of the trade day · 04/18~06/17

Claire Mazumdar's recent trades

Claire MazumdarOfficer, Director
Planned sale10b5-1 planBicara Therapeutics
Planned sale10b5-1 plan
Bicara Therapeutics
BCAX
$278.3K
10,000 sh
$278.3K
Filed 08/10
Traded 08/10
Claire MazumdarOfficer, Director
Planned sale10b5-1 planBicara Therapeutics
Planned sale10b5-1 plan
Bicara Therapeutics
BCAX
$296.8K
10,000 sh
$296.8K
Filed 07/10
Traded 07/10
Claire MazumdarCEO
Sell10b5-1 planBicara Therapeutics
Sell10b5-1 plan
Bicara Therapeutics
BCAX
$60.6K
2,978 sh
$60.6K
Filed 05/20
Traded 05/18
Claire MazumdarOfficer, Director
Planned sale10b5-1 planBicara Therapeutics
Planned sale10b5-1 plan
Bicara Therapeutics
BCAX
$313.8K
15,000 sh
$313.8K
Filed 05/18
Traded 05/18
Claire MazumdarCEO
Sell10b5-1 planBicara Therapeutics
Sell10b5-1 plan
Bicara Therapeutics
BCAX
$354.2K
15,000 sh
$354.2K
Filed 04/20
Traded 04/20

Claire Mazumdar, CEO — sold $240K of Bicara Therapeutics BCAX · 3.2% of holdings · 10b5-1 plan | Whalegun